Central Cancer Registry Reporting Content IG, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-central-cancer-registry-reporting-ig/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Central Cancer Registry Reporting Composition - Example - JSON Representation

Raw json | Download

{
  "resourceType" : "Composition",
  "id" : "ccrr-composition-example",
  "meta" : {
    "versionId" : "23",
    "lastUpdated" : "2021-08-19T22:06:32.441+00:00",
    "source" : "#6i8cijintDjJ8In2",
    "profile" : [
      🔗 "http://hl7.org/fhir/us/central-cancer-registry-reporting/StructureDefinition/ccrr-composition"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n  <p><b>Profile: </b> <a href=\"StructureDefinition-ccrr-composition.html\"> Central Cancer Registry Reporting Composition</a></p><h2>Central Cancer Registry Report</h2>\n  <p><b>Patient:</b> <a href=\"Patient-example.html\">Patient-example: Amy Shaw</a></p>\n  <p><b>Author:</b> <a href=\"Practitioner-1.html\">Practitioner 1: Dr. Nicholas Joseph</a></p>\n  <p><b>Date:</b> 2023-01-02</p>\n  <h3>Sections:</h3>\n  <ul>\n    <li><b>Primary Cancer Condition:</b> Infiltrating duct carcinoma of the left breast (<a href=\"Condition-primary-cancer-condition-breast.html\">Condition/primary-cancer-condition-breast</a>)</li>\n    <li><b>TNM Staging:</b> Stage IIA (cT2, cN0, cM0) (<a href=\"Observation-cancer-stage-group-example.html\">Observation/cancer-stage-group-example</a>)</li>\n    <li><b>Radiotherapy:</b> Completed external beam radiation therapy, photon modality, curative intent, Jan–Mar 2024 (<a href=\"Procedure-radiotherapy-example.html\">Procedure/radiotherapy-example</a>)</li>\n     <li><b>Medications:</b> Cancer-related medication administration (Docetaxel) (<a href=\"MedicationAdministration-cancer-med-admin-docetaxel-example.html\">MedicationAdministration/cancer-med-admin-docetaxel-example</a>)</li>\n  </ul>\n</div>"
  },
  "identifier" : {
    "value" : "c03eab8c-11e8-4d0c-ad2a-b385395e27db"
  },
  "status" : "final",
  "type" : {
    "coding" : [
      {
        "system" : "http://loinc.org",
        "code" : "72134-0"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/example",
    "display" : "Amy Shaw"
  },
  "encounter" : {
    🔗 "reference" : "Encounter/encounter-cancer-example",
    "display" : "Patient encounter procedure"
  },
  "date" : "2023-01-02T22:13:23Z",
  "author" : [
    {
      🔗 "reference" : "Practitioner/1",
      "display" : "Nicholas Joseph"
    }
  ],
  "title" : "Central Cancer Registry Report",
  "section" : [
    {
      "title" : "Primary Cancer Condition Section",
      "code" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "363346000",
            "display" : "Malignant neoplastic disease (disorder)"
          }
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Primary Cancer Condition Section</p></div>"
      },
      "entry" : [
        {
          🔗 "reference" : "Condition/primary-cancer-condition-breast"
        }
      ]
    },
    {
      "title" : "TNM Staging section",
      "code" : {
        "coding" : [
          {
            "system" : "http://loinc.org",
            "code" : "21908-9",
            "display" : "Stage group.clinical Cancer"
          }
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Cancer Stage Group</p></div>"
      },
      "entry" : [
        {
          🔗 "reference" : "Observation/cancer-stage-group-example"
        },
        {
          🔗 "reference" : "Observation/tnm-clinical-regional-nodes-category-cN0"
        },
        {
          🔗 "reference" : "Observation/tnm-clinical-primary-tumor-category-cT2"
        },
        {
          🔗 "reference" : "Observation/tnm-clinical-distant-metastases-category-cM0"
        }
      ]
    },
    {
      "title" : "Cancer Radio Therapy Course Summary section",
      "code" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "1217123003",
            "display" : "Radiotherapy course of treatment"
          }
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Cancer Radio Therapy Course Summary</p></div>"
      },
      "entry" : [
        {
          🔗 "reference" : "Procedure/radiotherapy-example"
        }
      ]
    },
    {
      "title" : "Medications Section",
      "code" : {
        "coding" : [
          {
            "system" : "http://loinc.org",
            "code" : "10160-0",
            "display" : "History of Medication use Narrative"
          }
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n Medications section: cancer-related medication </div>"
      },
      "entry" : [
        {
          🔗 "reference" : "MedicationAdministration/cancer-med-admin-docetaxel-example"
        }
      ]
    }
  ]
}